jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Pharmacy PracticeNOW IN
Article

Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients

Hege S. Blix1, Kirsten K. Viktil2, Tron A. Moger3, Aasmund Reikvam4

  1. 1PhD, MSc in Pharmacy. Lovisenberg Diakonale Hospital Pharmacy, Oslo / Department of Pharmacotherapeutics, Faculty of Medicine, University of Oslo / Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway.
  2. 2PhD, MSc in Pharmacy. Diakonhjemmet Hospital Pharmacy / Department of Pharmacotherapeutics, Faculty of Medicine, University of Oslo, Oslo, Norway.
  3. 3PhD, MSc in Statistics. Institute of Basic Medical Sciences, Department of Biostatistics, University of Oslo, Oslo, Norway.
  4. 4Professor, PhD, MD, FESC. Department of Pharmacotherapeutics, Faculty of Medicine, University of Oslo, Oslo, Norway.

Received: 11-09-2009; Accepted: 18-01-2010.

Volume 8, Issue 1 · pp. 50–55 · PUBLISHED Jan-Mar 2010 · DOI:

View on PP original site ↗

ABSTRACT

Drugs with narrow therapeutic index (NTI-drugs) are drugs with small differences between therapeutic and toxic doses. The pattern of drug-related problems (DRPs) associated with these drugs has not been explored. Objective: To investigate how, and to what extent drugs, with a narrow therapeutic index (NTI-drugs), as compared with other drugs, relate to different types of drug-related problems (DRPs) in hospitalised patients. Methods: Patients from internal medicine and rheumatology departments in five Norwegian hospitals were prospectively included in 2002. Clinical pharmacists recorded demographic data, drugs used, medical history and laboratory data. Patients who used NTI-drugs (aminoglycosides, ciclosporin, carbamazepine, digoxin, digitoxin, flecainide, lithium, phenytoin, phenobarbital, rifampicin, theophylline, warfarin) were compared with patients not using NTI-drugs. Occurrences of eight different types of DRPs were registered after reviews of medical records and assessment by multidisciplinary hospital teams. The drug risk ratio, defined as number of DRPs divided by number of times the drug was used, was calculated for the various drugs. Results: Of the 827 patients included, 292 patients (35%) used NTI-drugs. The NTI-drugs were significantly more often associated with DRPs than the non-NTI-drugs, 40% versus 19% of the times they were used. The drug risk ratio was 0.50 for NTI-drugs and 0.20 for non-NTI-drugs. Three categories of DRPs were significantly more frequently found for NTI-drugs: non-optimal dose, drug interaction, and need for monitoring. Conclusion: DRPs were more frequently associated with NTI-drugs than with non-NTI-drugs, but the excess occurrence was solely related to three of the eight DRP categories recorded. The drug risk ratio is a well-suited tool for characterising the risk attributed to various drugs.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Blix, H. S., Viktil, K. K., Moger, T. A., & Reikvam, A. (2010). Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients. Pharmacy Practice, 8(1), 50–55.